- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-estrogen Treatment in Endometrial Cancer: A Systematic Review
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-05-07
DOI
10.3389/fonc.2019.00359
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GOG 3007, a randomized phase II (RP2) trial of everolimus and letrozole (EL) or hormonal therapy (medroxyprogesterone acetate/tamoxifen, PT) in women with advanced, persistent or recurrent endometrial carcinoma (EC): A GOG Foundation study
- (2018) B.M. Slomovitz et al. GYNECOLOGIC ONCOLOGY
- Impact of oophorectomy and hormone suppression in low grade endometrial stromal sarcoma: A multicenter review
- (2018) L.E. Stewart et al. GYNECOLOGIC ONCOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer of the corpus uteri
- (2018) Frédéric Amant et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Is hormonal therapy effective in advanced endometrial cancer? A systematic review and meta-analysis
- (2017) Josee-Lyne Ethier et al. GYNECOLOGIC ONCOLOGY
- High mRNA levels of 17β-hydroxysteroid dehydrogenase type 1 correlate with poor prognosis in endometrial cancer
- (2017) Karlijn M.C. Cornel et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials
- (2017) Helen J. MacKay et al. Oncotarget
- The role of fulvestrant in endometrial cancer
- (2016) Stefano Bogliolo et al. Expert Opinion on Drug Metabolism & Toxicology
- Body mass index and aromatase inhibitors: a step forward in individualizing therapy for breast cancer patients?
- (2016) Agnieszka Słowik et al. Expert Review of Anticancer Therapy
- ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer
- (2016) Nicoletta Colombo et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Aromatase expression and regulation in breast and endometrial cancer
- (2016) Hong Zhao et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Chemotherapy for Endometrial Cancer in Adjuvant and Advanced Disease Settings
- (2016) Christine M. Bestvina et al. ONCOLOGIST
- Effectiveness of aromatase inhibitors in the treatment of advanced endometrial adenocarcinoma
- (2015) Stefano Bogliolo et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Phase II Study of Everolimus and Letrozole in Patients With Recurrent Endometrial Carcinoma
- (2015) Brian M. Slomovitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Endometrial Endometrioid Carcinoma Metastases Show Decreased ER-Alpha and PR-A Expression Compared to Matched Primary Tumors
- (2015) Carla Bartosch et al. PLoS One
- Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)
- (2014) Kristina Lindemann et al. BMC CANCER
- Selection of Personalized Patient Therapy through the Use of Knowledge-Based Computational Models That Identify Tumor-Driving Signal Transduction Pathways
- (2014) W. Verhaegh et al. CANCER RESEARCH
- Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: A gynecologic oncology group study
- (2014) Gini F. Fleming et al. GYNECOLOGIC ONCOLOGY
- Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors
- (2013) Suzanne George et al. CANCER
- Phase II study of fulvestrant 250mg/month in patients with recurrent or metastatic endometrial cancer: A study of the Arbeitsgemeinschaft Gynäkologische Onkologie
- (2013) Günter Emons et al. GYNECOLOGIC ONCOLOGY
- PET imaging of oestrogen receptors in patients with breast cancer
- (2013) Michel van Kruchten et al. LANCET ONCOLOGY
- Overexpression of 17β-Hydroxysteroid Dehydrogenase Type 1 Increases the Exposure of Endometrial Cancer to 17β-Estradiol
- (2012) Karlijn M. C. Cornel et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Evolution in Endometrial Cancer
- (2011) Ingrid Vandenput et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass
- (2011) Steven R. Goldstein et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Menopausal Hormone Therapy and Risk of Endometrial Carcinoma Among Postmenopausal Women in the European Prospective Investigation into Cancer and Nutrition
- (2010) N. E. Allen et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Functional oestrogen receptor α imaging in endometrial carcinoma using 16α-[18F]fluoro-17β-oestradiol PET
- (2010) Tetsuya Tsujikawa et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Phase II study of fulvestrant in recurrent/metastatic endometrial carcinoma: A Gynecologic Oncology Group Study
- (2010) Allan L. Covens et al. GYNECOLOGIC ONCOLOGY
- The efficacy of hormonal treatment for residual or recurrent low-grade endometrial stromal sarcoma. A retrospective study
- (2009) Taghride Dahhan et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More